06 October, 2016

FDA approves hybrid closed loop system for type 1 diabetes

Medtronic announced that it had received FDA approval for the world’s first hybrid closed loop (HCL) insulin delivery system – the MiniMed 670G system. It’s the company’s most advanced insulin pump and sensor system to date and provides patients living with diabetes more glucose control than ever before.

The system, which automatically adjusts the delivery of basal insulin, is also customizable so patients can choose from various levels of automation that best fit their management needs. The MiniMed 670G requires reduced patient interaction and uses the company’s most advanced SmartGuard™ HCL algorithm to minimize spikes and dangerous lows in blood sugar levels so patients feel better more often.
The system is approved for treatment of people living with type 1 diabetes 14 years of age and older. A clinical study is ongoing to evaluate the safety and efficacy of the therapy in children ages seven to 13, as well as a feasibility study evaluating the therapy in children ages two to six.
Medtronic will begin commercial release in Spring 2017.
Source: Medtronic

05 October, 2016

Disposable Colonoscope System Approved by FDA

GI View Ltd., developer of advanced GI screening systems, announced that it has received FDA 510(k) clearance for the new Aer-O-Scope® Colonoscope System, a disposable, self-propelled, joystickcontrolled, easy-to-use colonoscope system, now with therapeutic access. The new
system has two working channels that enable therapeutic access using standard tools, such as snares and forceps, to take biopsies or perform polypectomies.

The Aer-O-Scope is the first colonoscope to provide a 360° omni-directional visualization of the colon to detect polyps behind folds. There is also no risk of contamination or disease transmission between patients from the device as it is to be used only once and then disposed. The Aer-O-Scope employs a soft multi-lumen tube designed to significantly reduce pressure on the colon wall, which in turn, increases
patient safety. The tube is also hydrophilic, which reduces the friction between bowel and scope by more than 90%. Patient safety and comfort as well as physician ease of use are further maximized by the system’s self-propelled intubation, created using balloons and low pressure CO2 gas. As the system is joystick controlled it is also extremely simple to
operate and requires minimal training. Like all colonoscopes, the Aer-O-Scope provides insufflation, irrigation and suction.
Source: GI View Ltd

Detecting emotions with wireless signals

As many a relationship book can tell you, understanding someone else’s emotions can be a difficult task. Facial expressions aren’t always reliable: A smile can conceal frustration, while a poker face might mask a winning hand.
But what if technology could tell us how someone is really feeling?

Researchers from MIT’s Computer Science and Artificial Intelligence Laboratory (CSAIL) have developed “EQ-Radio,” a device that can detect a person’s emotions using wireless signals.
By measuring subtle changes in breathing and heart rhythms, EQ-Radio is 87 percent accurate at detecting if a person is excited, happy, angry or sad — and can do so without on-body sensors.
MIT professor and project lead Dina Katabi envisions the system being used in entertainment, consumer behavior, and health care. Film studios and ad agencies could test viewers’ reactions in real-time, while smart homes could use information about your mood to adjust the heating or suggest that you get some fresh air.
“Our work shows that wireless signals can capture information about human behavior that is not always visible to the naked eye,” says Katabi, who co-wrote a paper on the topic with PhD students Mingmin Zhao and Fadel Adib. “We believe that our results could pave the way for future technologies that could help monitor and diagnose conditions like depression and anxiety.”
EQ-Radio builds on Katabi’s continued efforts to use wireless technology for measuring human behaviors such as breathing and falling. She says that she will incorporate emotion-detection into her spinoff company Emerald, which makes a device that is aimed at detecting and predicting falls among the elderly.
Using wireless signals reflected off people’s bodies, the device measures heartbeats as accurately as an ECG monitor, with a margin of error of approximately 0.3 percent. It then studies the waveforms within each heartbeat to match a person’s behavior to how they previously acted in one of the four emotion-states.
Full Story is available from MIT website.

Delivering beneficial bacteria to the GI tract

The human digestive tract contains trillions of bacteria, many of which help digest food and fight off harmful bacteria. Recent studies have shown that some of these bacteria may influence, for better or worse, human diseases such as diabetes, heart disease, and cancer.

As scientists have learned more about these bacteria, many have raised the possibility that manipulating these populations, known collectively as the microbiome, could improve human health.
Looking toward that future, a team of MIT scientists has developed a strategy for delivering large numbers of beneficial bacterial to the human gut.
“Once the microbiome is better understood, we can use this delivery platform to target certain areas and introduce certain species there,” says Ana Jaklenec, a research scientist at MIT’s Koch Institute for Integrative Cancer Research and one of the senior authors of a paper describing this approach in the Sept. 12 issue of the journal Advanced Materials.
Jaklenec and colleagues developed a way to coat bacteria with polymer layers that protect them from the acids and bile salts found in the digestive tract. When the microbes reach the intestine, they attach to the intestinal lining and begin reproducing.
“The bacteria are delivered and they adhere to the intestinal wall, where they survive much better than noncoated bacteria,” says Koch Institute postdoc Aaron Anselmo, the paper’s first author.
Full story is available from MIT website.

iBeat and Dr. Mehmet Oz To Launch Lifesaving Smartwatch

Mehmet Oz, called America’s Doctor by many, has joined with health tech startup iBeat to launch a breakthrough heart monitoring smartwatch that empowers people to live longer lives. The partnership with Dr. Oz will kick off with pre-orders for its iBeat Life Monitor – a watch that continuously monitors one’s heart for life threatening emergencies and notifies loved ones and emergency responders in such an event. A world renowned leader in cardiothoracic surgery, a transplant surgeon, and holder of eight patents, Dr. Oz has saved thousands of lives both in the operating room and by educating his millions of viewers. After seeing the massive impact potential of the iBeat technology in their San Francisco headquarters, Oz invested, partnered with, and joined on as Special Advisor to the company.

“The iBeat Life Monitor was designed to continuously measure and monitor one’s heart and potentially prevent fatal heart incidents,” said Dr. Oz, seven-time Emmy Award winning host of the nationally syndicated “The Dr. Oz Show.” “This medical-grade device not only provides users with a sense of safety and control over their own heart health – which is vital in the treatment and prevention of heart failure – but also allows their loved ones and family members to take a more observant role in their care as well. To make a positive impact on the health of others, I’ve learned that we need to make it easy to do the right thing. This device is not only a technological breakthrough that will be more effective than anything on the market, it fits into a person’s wardrobe with style and ease, making it simple to integrate its lifesaving properties in one’s everyday routine. As Special Advisor, I look forward to raising awareness around preventing life-threatening heart issues and highlighting a device that can truly save lives.”
The iBeat Life Monitor differentiates itself from other wearables on the market by continuously monitoring and analyzing user’s heart activity and instantly detecting the signs of oncoming cardiac arrest (a sudden cessation of heart function). If the device detects a life-threatening heart emergency, it will engage the user and ask if he or she is ‘OK.’ If the user selects ‘No’ or is unresponsive, iBeat will instantly alert the user’s loved ones and emergency responders in real-time, helping ensure immediate care delivery and potentially saving the user’s life.
The iBeat Life Monitor does not need a cell phone, mobile app, Bluetooth connectivity, or Wi-Fi to function. The device is fully cellular, while built-in GPS ensures the user’s loved ones and first response teams know exactly where the user is in an emergency. In such an instance, emergency contacts will get a text with a link showing where the user is and where they are in-transit so they can meet them at the hospital or nearby care center. Users will also have access to an online dashboard where they can see their daily, weekly, and monthly overall heart health (beats per minutes, heart pattern changes, etc.) and compare it to others within their age range. The device is also equipped with an Emergency-On-Demand button which, when long-pressed for two seconds, will allow users to reach out to their emergency contacts, or if needed, 911.
While the watch is primarily targeted at baby-boomers, especially those who live alone, and individuals with existing heart conditions, the device is receiving notable interest from younger adults and millennials who have parents and grandparents that could greatly benefit from the device. iBeat has already raised $1.5 million in funding from private investors and is looking to establish the market for the iBeat Life Monitor through pre-orders, as well as support the tooling and production line needed to bring the device to the masses.
“The early interest we’ve seen in iBeat has been remarkable,” said Ryan Howard, founder and CEO of iBeat. “We are excited to bring our device to the Indiegogo platform to drive even more awareness around the product and its ability to potentially save someone’s life. If you suffer a life-threatening heart incident such as sudden cardiac arrest, you have a 90% chance of dying without intervention. There are many devices on the market including diabetic monitors, heart-rate monitors, and other health monitoring solutions, but all these devices only passively monitor you. None of them actively monitor and analyze your heart health around-the-clock like the iBeat Life Monitor. Continual monitoring and quick intervention can mean the difference between life and death in emergency situations.”
Source: iBeat